| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EUROPACE/EUW378 |
| P698 | PubMed publication ID | 28017937 |
| P50 | author | Karl-Heinz Kuck | Q1729904 |
| Francesco Santoro | Q38800229 | ||
| P2093 | author name string | Ardan M Saguner | |
| Kentaro Hayashi | |||
| Andreas Metzner | |||
| Erik Wissner | |||
| Feifan Ouyang | |||
| Peter Wohlmuth | |||
| Christian Sohns | |||
| Christine Lemes | |||
| Johannes Riedl | |||
| Shibu Mathew | |||
| Thomas Fink | |||
| Tilman Maurer | |||
| Bruno Reißmann | |||
| Christian H Heeger | |||
| P2860 | cites work | Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study | Q34634328 |
| Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. | Q35531789 | ||
| Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community | Q35885942 | ||
| Healing after myocardial infarction | Q36071600 | ||
| Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses | Q37609736 | ||
| Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. | Q37684527 | ||
| Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. | Q38279834 | ||
| Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis | Q38432526 | ||
| Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation | Q39150012 | ||
| Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures | Q39199350 | ||
| Short tip-big difference? First-in-man experience and procedural efficacy of pulmonary vein isolation using the third-generation cryoballoon | Q40274087 | ||
| Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success. | Q41285025 | ||
| Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy | Q43612801 | ||
| Impact of structural heart disease on the acute complication rate in atrial fibrillation ablation: results from the German Ablation Registry | Q44007231 | ||
| Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up | Q44119179 | ||
| Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation | Q45091713 | ||
| Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. | Q45999295 | ||
| Complications of catheter ablation for atrial fibrillation: incidence and predictors | Q46433037 | ||
| Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation | Q46466505 | ||
| Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation | Q48283179 | ||
| The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy. | Q51040266 | ||
| Approaches to catheter ablation for persistent atrial fibrillation. | Q52866999 | ||
| Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of Age | Q56607940 | ||
| 2012 focused update of the ESC Guidelines for the management of atrial fibrillation | Q57312493 | ||
| P921 | main subject | catheter ablation | Q436572 |
| Atrial Fibrillation | Q815819 | ||
| P577 | publication date | 2016-12-25 | |
| P1433 | published in | EP Europace | Q2596718 |
| P1476 | title | Catheter ablation of atrial fibrillation in very young adults: a 5-year follow-up study |
Search more.